Innovation
The research funded by Stand Up to Cancer
Stand Up to Cancer funds scientific research for lung, breast, pancreatic, and ovarian cancer. Meet the dream team and their research.
Are you watching Stand Up to Cancer tonight?
Curing cancer is like making movies, filmmaker Laura Ziskin said in the CNN video below.
Ziskin is a breast cancer survivor and a co-creator of Stand Up to Cancer. Her mission is to make cancer entertaining. So far, Stand Up to Cancer has raised $83 million for scientific research.
The dream teams have been busy:
- Epigenetic Therapies, an experimental treatment at Johns Hopkins, to reprogram rather than poison cancer cells. Researchers saw the benefits in patients with advanced lung cancer and plan to apply this treatment to other types of cancers.
- targeting PI3K in women's cancers such as breast, ovarian, uterine and endometrial cancers.
- on pancreatic cancer: “Every single person on this team has lost somebody to pancreatic cancer… many of us see patients with it every single day… We can do things, we can help with their pain, we can improve their survival some. But we want to do something dramatic.” Dr. Daniel D. Von Hoff, M.D
- circulating tumor chip cell taps the sensitivity of microfluidics.
- targeting breast cancer subtypes. Breast cancer is not just one disease.
This post was originally published on Smartplanet.com